Veeva Systems Inc.
NYSE:VEEVMedical - Healthcare Information Services
-$2.83 today
- Market cap
- $44.88B
- Beta
- 0.95
- P/E (TTM)
- 26.4
- EPS (TTM)
- $5.76
Volume 2.74M
Average 3.01M
VEEV Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Veeva Systems Inc.NYSE: VEEV
Stock-Based Compensation · Q2 FY2027 · quarter ended Jul 2026
Stock-based compensation turns positive
Q2 FY2027 stock-based compensation was $136.8M, compared with -$1.94M a year earlier. Trailing-twelve-month stock-based compensation was $255.23M.
Context
- Stock-based compensation amounted to 14.8% of revenue in FY2026, up 14.8 pp from a year earlier.
- Stock-based compensation increased in 1 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly stock-based compensation holds near $136.8M or moves back toward the trailing-twelve-month quarterly average of $63.81M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2026
- 472.7M USD
- Year-over-year change
- —
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 472.7M | — |
| FY2025 | 2025-01-31 | 0 | — |
| FY2024 | 2024-01-31 | 0 | — |
| FY2023 | 2023-01-31 | 0 | — |
| FY2022 | 2022-01-31 | 0 | — |
Stock-Based Compensation vs competitors
How VEEV compares with its peers on the latest reported figures
- VEEV's LTM Jul 2026 stock-based compensation of $255.23M is the 2nd largest of the 5 companies compared; the peer median is $91.68M.
- Its year-over-year change of +120.2% is the highest of 5, against a peer median of +41.9%.
- Stock-based compensation amounts to 7.4% of revenue for VEEV, versus a peer median of 8.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $275M | +17.5% | +8.4% | 1.6% | |
| LTM Jul 2026 | $255.23M | +120.2% | — | 7.4% | |
| LTM Sep 2026 | $147.61M | +66.3% | +36.5% | 22.3% | |
| LTM Sep 2026 | $35.75M | -21.5% | +2.8% | 13.3% | |
| LTM Mar 2026 | $8.35M | +85.0% | +31.8% | 2.7% | |
| Peer median (excluding VEEV) | $91.68M | +41.9% | +20.1% | 8.0% | |
Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 427.39M | 487.71M | 525.71M | 714.14M | 908.91M |
| Depreciation & Amortization | 36.97M | 37.66M | 37.15M | 50.93M | 50.47M |
| Deferred Income Tax | 11.08M | (127.5M) | (105.37M) | (112.27M) | 65.09M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 472.7M |
| Change in Working Capital | 20.66M | 7.34M | 60.82M | 7.62M | (91.94M) |
| Accounts Receivables | (83.08M) | (91.09M) | (104M) | (168.97M) | (254.55M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (3M) | 21.43M | (10.23M) | (1.96M) | 6.08M |
| Other Working Capital | 106.74M | 77M | 175.05M | 178.55M | 156.53M |
| Other Non-Cash Items | 268.37M | 375.26M | 393.03M | 429.64M | 9.99M |
| Operating Cash Flow | 764.46M | 780.47M | 911.34M | 1.09B | 1.42B |
| Capital Expenditures | (14.21M) | (13.51M) | (26.2M) | (20.52M) | (29.13M) |
| Acquisitions (Net) | (7.78M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.12B) | (2B) | (2.7B) | (2.58B) | (3.13B) |
| Sales of Investments | 792.92M | 1B | 1.65B | 1.9B | 2.06B |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (346.15M) | (1.01B) | (1.08B) | (700.14M) | (1.1B) |
| Debt Repayment | (384K) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 51.54M | 43.65M | 62.69M | 105.54M | 253.86M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (169.95M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (55.29M) | (63.03M) | (78.88M) | (79.42M) | (93.25M) |
| Financing Cash Flow | (4.14M) | (19.38M) | (16.19M) | 26.12M | (9.33M) |
| Effect of Forex Changes | (4.66M) | (4.99M) | (1.78M) | (1.74M) | 919K |
| Net Change in Cash | 409.51M | (251.58M) | (182.98M) | 414.29M | 302.45M |
| Free Cash Flow | 750.25M | 766.96M | 885.14M | 1.07B | 1.39B |
Veeva Systems Inc.
NYSE:VEEV
Intrinsic Alpha fair value
Locked
Current Price
$277.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.